drugset / Trial / NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This is an open-label, Phase 1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced or metastatic solid tumors with particular focus on Colorectal carcinoma (CRC).
Timeline
- Start
- 2024-06-18
- Primary completion
- 2027-04
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APL-5125 | Unknown | — | Oral |